Last reviewed · How we verify
NCT04269109
Opioid Sparing Pain Management Strategy
trial testing Multi-modal Opioid Sparing Pain Management Protocol in Cardiac Surgical Procedures in 150 participants. Completed in 1 March 2021.
30 April 2019
Quick facts
| Lead sponsor | Prisma Health-Upstate |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 September 2018 |
| Primary completion | 30 April 2019 |
| Estimated completion | 1 March 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Multi-modal Opioid Sparing Pain Management Protocol
Conditions studied
- Cardiac Surgical Procedures — all drugs for Cardiac Surgical Procedures →
Sponsor
Prisma Health-Upstate — full company profile →
Who can join
18 and older, any sex, with Cardiac Surgical Procedures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study is to compare the amount of morphine milligram equivalents consumed post operatively until discharge between the control cohort and intervention cohort.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04269109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Surgical Procedures
Currently open trials in the same condition.
- NCT07348510 — Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures · NA · recruiting
- NCT06952907 — Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients · NA · recruiting
- NCT06318689 — In Situ Exploration of Vascular Function in Vasoplegic Shock Following Cardiac Surgery With Cardiopulmonary Bypass · recruiting
- NCT04244981 — Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery · Phase 4 · recruiting
Other Prisma Health-Upstate trials
Trials by the same sponsor.
- NCT07202039 — Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine · NA · not yet recruiting
- NCT07375212 — VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure · Phase 4 · withdrawn
- NCT07102615 — Intracervical Vasopressin · Phase 4 · recruiting
- NCT07101250 — Preoperative Acetazolamide · Phase 4 · recruiting
- NCT06874413 — Targeted Prehabilitation With Physical Exercise and Inspiratory Muscle Training for Elderly Frail Patients Prior to Vent · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04269109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prisma Health-Upstate
- Last refreshed: 13 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04269109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing